会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Network attached virtual tape data storage subsystem
    • 网络连接的虚拟磁带数据存储子系统
    • US06529996B1
    • 2003-03-04
    • US09343512
    • 1999-06-30
    • Thai NguyenRobert Michael RaymondMichael Lawrence Leonhardt
    • Thai NguyenRobert Michael RaymondMichael Lawrence Leonhardt
    • G06F1200
    • G11B15/68G06F3/0626G06F3/0664G06F3/067
    • The network attached virtual tape storage subsystem interconnects a plurality of tape devices with a plurality of data processors via a high bandwidth switching network to implement a virtual, distributed tape data storage subsystem. The virtual, distributed tape data storage system realizes multiple virtual devices, which are available to any of the data processors and the bandwidth of the system is scalable and can be changed on demand. The virtual tape storage subsystem is managed by a system controller which contains a plurality of software elements including: resource allocation, resource configuration, and resource management. The use of a networked storage manager enables the tape devices to be managed as a pool and yet attach the tape devices directly to the network as individual resources. The networked storage manager must provide the mechanism for the enterprise management to control tape device allocation and configuration as well as other functions, such as tape cartridge movement and data migration.
    • 网络连接的虚拟磁带存储子系统通过高带宽交换网络将多个磁带设备与多个数据处理器互连,以实现虚拟的分布式磁带数据存储子系统。 虚拟分布式磁带数据存储系统实现多个虚拟设备,这些虚拟设备可用于任何数据处理器,并且系统的带宽是可扩展的,可以根据需要进行更改。 虚拟磁带存储子系统由包含多个软件元素的系统控制器管理,包括:资源分配,资源配置和资源管理。 使用网络存储管理器可以将磁带设备作为池进行管理,并将磁带设备作为个别资源直接附加到网络。 网络存储管理器必须提供企业管理机制来控制磁带设备分配和配置以及其他功能,如磁带盒移动和数据迁移。
    • 2. 发明授权
    • 5-arylpyrimidines as anticancer agents
    • 5-芳基嘧啶作为抗癌剂
    • US07524849B2
    • 2009-04-28
    • US10950375
    • 2004-09-24
    • Nan ZhangSemiramis Ayral-KaloustianThai Nguyen
    • Nan ZhangSemiramis Ayral-KaloustianThai Nguyen
    • C07D239/42C07D239/48A61K31/505
    • C07D239/42A61K31/505A61K31/506C07D239/48C07D401/04C07D403/04C07D405/04C07D409/04
    • This invention relates to certain 5-arylpyrimidine compounds or a pharmaceutically acceptable salt thereof, and compositions containing said compounds or a pharmaceutically acceptable salt thereof, wherein said compounds are anti-cancer agents useful for the treatment of cancer in mammals. This invention further relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal and further provides a method for the treatment or prevention of cancerous tumors that express multiple drug resistance (MDR) or are resistant because of MDR, in a mammal in need thereof which method comprises administering to said mammal an effective amount of said compounds or a pharmaceutically acceptable salt thereof.More specifically, the present invention relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal in need thereof by promotion of microtubule polymerization which comprises administering to said mammal an effective amount of said compounds and pharmaceutically acceptable salts thereof.
    • 本发明涉及某些5-芳基嘧啶化合物或其药学上可接受的盐,以及含有所述化合物或其药学上可接受的盐的组合物,其中所述化合物是可用于治疗哺乳动物癌症的抗癌剂。 本发明还涉及治疗或抑制哺乳动物中癌性肿瘤细胞和相关疾病的生长的方法,并进一步提供了治疗或预防表达多重耐药性(MDR)或耐多药耐药性的癌性肿瘤的方法 在需要的哺乳动物中,所述方法包括向所述哺乳动物施用有效量的所述化合物或其药学上可接受的盐。 更具体地,本发明涉及通过促进微管聚合来治疗或抑制有需要的哺乳动物中癌性肿瘤细胞和相关疾病的生长的方法,其包括向所述哺乳动物施用有效量的所述化合物和药学上可接受的盐 其中。
    • 4. 发明申请
    • 5-arylpyrimidines as anticancer agents
    • 5-芳基嘧啶作为抗癌剂
    • US20050075357A1
    • 2005-04-07
    • US10950375
    • 2004-09-24
    • Nan ZhangSemiramis Ayral-KaloustianThai Nguyen
    • Nan ZhangSemiramis Ayral-KaloustianThai Nguyen
    • A61K31/505A61K31/506A61P35/00C07D239/42C07D239/48C07D401/04C07D403/04C07D405/04C07D409/04A61K31/513C07D43/02
    • C07D239/42A61K31/505A61K31/506C07D239/48C07D401/04C07D403/04C07D405/04C07D409/04
    • This invention relates to certain 5-arylpyrimidine compounds or a pharmaceutically acceptable salt thereof, and compositions containing said compounds or a pharmaceutically acceptable salt thereof, wherein said compounds are anti-cancer agents useful for the treatment of cancer in mammals. This invention further relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal and further provides a method for the treatment or prevention of cancerous tumors that express multiple drug resistance (MDR) or are resistant because of MDR, in a mammal in need thereof which method comprises administering to said mammal an effective amount of said compounds or a pharmaceutically acceptable salt thereof. More specifically, the present invention relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal in need thereof by promotion of microtubule polymerization which comprises administering to said mammal an effective amount of said compounds and pharmaceutically acceptable salts thereof.
    • 本发明涉及某些5-芳基嘧啶化合物或其药学上可接受的盐,以及含有所述化合物或其药学上可接受的盐的组合物,其中所述化合物是可用于治疗哺乳动物癌症的抗癌剂。 本发明还涉及治疗或抑制哺乳动物中癌性肿瘤细胞和相关疾病的生长的方法,并进一步提供了治疗或预防表达多重耐药性(MDR)或耐多药耐药性的癌性肿瘤的方法 在需要的哺乳动物中,所述方法包括向所述哺乳动物施用有效量的所述化合物或其药学上可接受的盐。 更具体地,本发明涉及通过促进微管聚合来治疗或抑制有需要的哺乳动物中癌性肿瘤细胞和相关疾病的生长的方法,其包括向所述哺乳动物施用有效量的所述化合物和药学上可接受的盐 其中。
    • 5. 发明授权
    • Network attached virtual data storage subsystem
    • 网络连接的虚拟数据存储子系统
    • US06658526B2
    • 2003-12-02
    • US09421916
    • 1999-10-20
    • Thai NguyenRobert M. RaymondMichael L. Leonhardt
    • Thai NguyenRobert M. RaymondMichael L. Leonhardt
    • G06F1200
    • G06F3/0613G06F3/0664G06F3/067G06F3/0686
    • This data storage subsystem creates multiple virtual storage devices on demand, which are available to any and all of the system's host data processors. The subsystem utilizes a plurality of tape devices and automated tape libraries with the tape devices connected to a plurality of data processors via a high-speed network. A set of software components, the Network Storage Manager (NSM) controls all system operations. Depending upon the requested storage performance, one or more tape devices are assigned to a virtual device. Data stripping across multiple tape devices allows the storage bandwidth of a virtual device to be changed on demand. The overall capacity and performance of the subsystem is scalable by adding or removing storage devices. The NSM system controller contains a plurality of software elements including: Resource Allocation, Resource Configuration, Resource Management, and Security Management modules. The use of a networked storage manager enables the storage devices to be managed as a pool and yet be attached directly to the network as individual resources. The NSM also provides the mechanism for the enterprise management to control tape device allocation and configuration as well as other functions, such as tape cartridge movement, data migration and data security.
    • 该数据存储子系统根据需要创建多个虚拟存储设备,可用于任何和所有系统的主机数据处理器。 子系统利用多个磁带设备和自动磁带库,磁带设备经由高速网络连接到多个数据处理器。 一组软件组件,网络存储管理器(NSM)控制所有系统操作。 根据请求的存储性能,将一个或多个磁带设备分配给虚拟设备。 跨多个磁带设备的数据剥离允许虚拟设备的存储带宽根据需求进行更改。 通过添加或删除存储设备可以扩展子系统的整体容量和性能。 NSM系统控制器包含多个软件元素,包括:资源分配,资源配置,资源管理和安全管理模块。 使用网络存储管理器可以将存储设备作为池进行管理,并将其作为个别资源直接连接到网络。 NSM还提供了企业管理控制磁带设备分配和配置以及其他功能(如磁带盒移动,数据迁移和数据安全性)的机制。
    • 6. 发明授权
    • Optical microscope stage for scanning probe microscope
    • 扫描探针显微镜的光学显微镜镜
    • US06310342B1
    • 2001-10-30
    • US09128885
    • 1998-08-04
    • David BraunsteinMichael KirkQuoc LyThai Nguyen
    • David BraunsteinMichael KirkQuoc LyThai Nguyen
    • H01J3720
    • G01Q10/04G01Q30/025Y10S977/849Y10S977/86Y10S977/868Y10S977/869Y10S977/87Y10S977/872Y10S977/873
    • Scanning probe microscopes and scanning probe heads are provided having improved optical visualization and sample manipulation capabilities. The SPMs and SPM heads include at least one flexure stage for scanning in the x, y and/or z directions. In a preferred embodiment, the SPMs or SPM heads include flexure stages for scanning in the x, y and z directions. The z scanning stage is preferably positioned outside the lateral footprint of the x-y flexure stage so that a probe extending from the z scanning stage is outside the lateral footprint of the instrument. The SPMs and SPM heads are configured to provide top down and bottom up optical views of the sample and/or the probe and enable simultaneous scanning probe microscopy and optical imaging of a sample to be performed. The SPMs and SPM heads are designed to be readily combinable with existing upright and inverted optical microscopes currently available from various major manufacturers.
    • 提供扫描探针显微镜和扫描探头,具有改进的光学可视化和样品操作能力。 SPM和SPM头包括用于在x,y和/或z方向扫描的至少一个弯曲台。 在优选实施例中,SPM或SPM头包括用于在x,y和z方向扫描的挠曲台。 z扫描台优选地定位在x-y弯曲台的横向覆盖区的外侧,使得从z扫描台延伸的探针位于仪器的横向覆盖区之外。 SPM和SPM头被配置为提供样品和/或探针的自顶向下和从底部的光学视图,并且能够执行样品的同时扫描探针显微镜和光学成像。 SPM和SPM头设计为可以与现有的各种主要制造商现有的直立和倒置光学显微镜组合。
    • 9. 发明授权
    • Method and apparatus for calibrating filtering of a transceiver
    • 用于校准收发器过滤的方法和装置
    • US07437139B2
    • 2008-10-14
    • US11258701
    • 2005-10-26
    • Steve LoIsaac SeverThai NguyenSsu-Pin Ma
    • Steve LoIsaac SeverThai NguyenSsu-Pin Ma
    • H04B1/16
    • H04B1/1027
    • A method and apparatus of calibrating filtering of receive and transmit signals is disclosed. The method of calibrating filtering of a received signal includes injecting an LO signal. The injected LO signal is filtered by a tunable filter. The filtered signal is frequency down-converted with an equivalent LO signal. The frequency down-converted signal is sampled while tuning the filtering. A desired filter tuning is determined based upon the samples and a frequency of the LO signal. The method of calibrating filtering of a transmit signal includes injecting an LO signal to a transmitter. The LO signal is filtered by a tunable filter. The filtered signal is frequency down-converted with an equivalent LO signal. The frequency down-converted signal is sampled while tuning the filter. A desired filter tuning is determined based upon the samples and a frequency of the LO signal.
    • 公开了一种校准接收和发送信号的滤波的方法和装置。 对接收信号进行校准滤波的方法包括:注入LO信号。 注入的LO信号被可调滤波器滤波。 滤波后的信号用等效的LO信号进行降频转换。 在对滤波进行调谐的同时对降频转换信号进行采样。 基于样本和LO信号的频率来确定期望的滤波器调谐。 校准发射信号的滤波的方法包括将LO信号注射到发射机。 LO信号由可调谐滤波器滤波。 滤波后的信号用等效的LO信号进行降频转换。 在对滤波器进行调谐的同时采样降频转换信号。 基于样本和LO信号的频率来确定期望的滤波器调谐。